📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: B-MoGen

1.1 - Company Overview

B-MoGen Logo

B-MoGen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of genome engineering solutions, including the TcBuster Transposon System, a non-viral genetic modification method for delivering therapeutic payloads to diverse cell types, enabling rapid transgenic mammalian cell generation, multigene transfer, and CRISPR-mediated knockouts; and ScaleReady, a partnership that reduces complexity and cost in immune cell therapy and supports scalable immune cell expansion with platform, process, and product continuity.

Products and services

  • Genome Engineering IP Licensing & Collaborative Projects: Licenses and develops novel genome engineering intellectual property and executes projects for clients in academia and industry through strategic partnerships to advance genome engineering
  • ScaleReady: A partnership offering that reduces complexity and cost in immune cell therapy, supporting scalable immune cell expansion with platform, process, and product continuity
  • TcBuster Transposon System: Non-viral genetic modification system delivering therapeutic payloads to diverse cell types, rapidly generating transgenic mammalian cells and supporting multigene transfer and CRISPR-mediated knockouts

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to B-MoGen

Tara Biosystems Logo

Tara Biosystems

HQ: United States Website
  • Description: Provider of predictive, in vitro human cardiac tissue models for drug discovery, safety assessment, and translational medicine, based on human stem cell-derived cardiac tissue matured to physiologically relevant adult-like levels, offering a high-fidelity solution.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tara Biosystems company profile →
Singulex Logo

Singulex

HQ: United States Website
  • Description: Provider of direct molecular detection and cardiovascular monitoring solutions, including the Singulex Clarity System, an automated in vitro diagnostics platform using Single Molecule Counting technology for precise, ultra-low-level biomarker measurement across a 6-log reporting range, and the Singulex cTnI Assay for femtogram-per-milliliter cardiac troponin I quantitation to aid cardiovascular disease diagnosis and management.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Singulex company profile →
Synthego Logo

Synthego

HQ: United States Website
  • Description: Provider of genome engineering platforms enabling access to CRISPR to accelerate life science R&D, leveraging machine learning, automation, and gene editing. Offers synthetic and synthesized sgRNA/gRNA for research and therapeutic development, GMP-grade and IND-enabling sgRNA for clinical trials and pre-IND studies, and the engineered hfCas12Max nuclease for higher on-target editing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synthego company profile →
Biosyntia Logo

Biosyntia

HQ: Denmark Website
  • Description: Provider of synthetic biology and metabolic engineering solutions, developing biocatalysts and tailored biocatalysis processes using patent-pending high-throughput screening. Offers BIO-B7 natural biotin (high-purity, traceable), Eraglow skincare actives based on fermented biotin, and Forskeffect botanical forskolin. Provides Biosynthetic Selections for ultra-high-throughput testing of engineered microorganisms and partnering on fermentation process development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biosyntia company profile →
Avitide Logo

Avitide

HQ: United States Website
  • Description: Provider of customized affinity purification solutions for biopharmaceuticals, including AVIPure affinity resins for custom and platform use, proprietary solutions to improve bioprocessing and manufacturing, a flexible, scalable commercial resin supply supported by ISO 9001:2015 operations, regulatory support and documentation, and AVIPure-AAV8 for single-step AAV8 purification with high yield, purity, and capacity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avitide company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for B-MoGen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to B-MoGen

2.2 - Growth funds investing in similar companies to B-MoGen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for B-MoGen

4.2 - Public trading comparable groups for B-MoGen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to B-MoGen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About B-MoGen

What does B-MoGen do?

B-MoGen is a provider of genome engineering solutions, including the TcBuster Transposon System, a non-viral genetic modification method for delivering therapeutic payloads to diverse cell types, enabling rapid transgenic mammalian cell generation, multigene transfer, and CRISPR-mediated knockouts; and ScaleReady, a partnership that reduces complexity and cost in immune cell therapy and supports scalable immune cell expansion with platform, process, and product continuity.

Who are B-MoGen's competitors?

B-MoGen's competitors and similar companies include Tara Biosystems, Singulex, Synthego, Biosyntia, and Avitide.

Where is B-MoGen headquartered?

B-MoGen is headquartered in United States.

How many employees does B-MoGen have?

B-MoGen has 1,000 employees 🔒.

When was B-MoGen founded?

B-MoGen was founded in 2010 🔒.

What sector and industry vertical is B-MoGen in?

B-MoGen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for B-MoGen

Who are the top strategic acquirers in B-MoGen's sector and industry

Top strategic M&A buyers and acquirers in B-MoGen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for B-MoGen?

Top strategic M&A buyers groups and sectors for B-MoGen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in B-MoGen's sector and industry vertical

Which are the top PE firms investing in B-MoGen's sector and industry vertical?

Top PE firms investing in B-MoGen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in B-MoGen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in B-MoGen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in B-MoGen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to B-MoGen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in B-MoGen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for B-MoGen?

The key public trading comparables and valuation benchmarks for B-MoGen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for B-MoGen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for B-MoGen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in B-MoGen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for B-MoGen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in B-MoGen's' sector and industry vertical?

Access recent funding rounds and capital raises in B-MoGen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for B-MoGen